Expression of Programmed Cell Death-1 (PD-1) and Its Ligand (PD-L1) in Breast Cancers and Its Association with Clinicopathological Parameters: A Study from North India

Expression of Programmed Cell Death-1 (PD-1) and Its Ligand (PD-L1) in Breast Cancers and Its Association with Clinicopathological Parameters: A Study from North India

Introduction Cancer immunotherapy targeting the programmed cell death ligand 1 (PD-L1) and programmed cell death-1 (PD-1) axis has revolutionized cancer therapy. PD-L1 also serves as a predictive marker for such therapy. To assess the potential of such therapy in any cancer, the positivity of PD-1 a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anoushika Mehan, Michael Leonard Anthony, Pranoy Paul, Anjum Syed, Nilotpal Chowdhury, Shalinee Rao, Nuzhat Hussain, Bina Ravi
Formato: article
Lenguaje:EN
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Materias:
programmed cell death 1 ligand 1
programmed cell death 1 receptor
breast carcinoma
Medicine
R
Acceso en línea:https://doaj.org/article/3e7680abb3dd43d2ad4124ebd1b85cd7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/3e7680abb3dd43d2ad4124ebd1b85cd7

Ejemplares similares